Cellular Interactions in Cell Sheets Enhance Mesenchymal Stromal Cell Immunomodulatory Properties
Tissue Engineering Part A · 01.11.2023 · 29 (21-22) · 594-603
DOI: 10.1089/ten.tea.2023.0059 ↗Kurz gefasst
Fachartikel in der Zeitschrift Tissue Engineering Part A, erschienen am 01.11.2023. Verfasst von Celia M Dunn und 6 weiteren Autor:innen. Beteiligte Einrichtung: Cell Sheet Tissue Engineering Center (CSTEC), Department of Molecular Pharmaceutics, University of Utah, Salt Lake City, Utah, USA. Hauptthemen laut MEDLINE: Mesenchymal Stem Cells. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 57 Literaturangaben.
Abstract (Originalsprache)
Immune-related applications of mesenchymal stromal cells (MSCs) in cell therapy seek to exploit immunomodulatory paracrine signaling pathways to reduce inflammation. A key MSC therapeutic challenge is reducing patient outcome variabilities attributed to insufficient engraftment/retention of injected heterogenous MSCs. To address this, we propose directly transplantable human single-cell-derived clonal bone marrow MSC (hcBMSC) sheets. Cell sheet technology is a scaffold-free tissue engineering strategy enabling scalable production of highly engraftable cell constructs retaining endogenous cell-cell and cell-matrix interactions, important to cell function. cBMSCs, as unique MSC subset populations, facilitate rational selection of therapeutically relevant MSC clones from donors. Here, we combine human cBMSCs with cell sheet technology, demonstrating cell sheet fabrication as a method to significantly upregulate expression of immunomodulatory molecules interleukin (IL)-10, indoleamine 2,3-dioxygenase (IDO-1), and prostaglandin E synthase 2 (PTGES2) across GMP-grade hcBMSC lines and whole human bone marrow-derived MSCs compared to respective conventional cell suspensions. When treated with carbenoxolone, a gap junction inhibitor, cell sheets downregulate IL-10 and IDO-1 expression, implicating functional roles for intercellular sheet interactions. Beyond producing directly transferable multicellular hcBMSC constructs, cell sheet technology amplifies hcBMSC expression of immunomodulatory factors important to therapeutic action. In addition, this work demonstrates the importance of cell-cell interactions as a tissue engineering design criterion to enhance consistent MSC functions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Cell Sheet Tissue Engineering Center (CSTEC), Department of Molecular Pharmaceutics, University of Utah, Salt Lake City, Utah, USA.
- Department of Biomedical Engineering, University of Utah, Salt Lake City, Utah, USA.
- SCM Lifescience Co., Ltd., Incheon, Republic of Korea.
- Institute for Advanced Biomedical Sciences, Tokyo Women's Medical University, Tokyo, Japan.
ORCID-Profile: Celia M Dunn, Sumako Kameishi
Zitieren
APA
Dunn, C. M., Kameishi, S., Parker, T., Cho, Y. K., Song, S. U., Grainger, D. W., & Okano, T. (2023). Cellular Interactions in Cell Sheets Enhance Mesenchymal Stromal Cell Immunomodulatory Properties. Tissue Engineering Part A, 29(21-22), 594-603. https://doi.org/10.1089/ten.tea.2023.0059
Vancouver
Dunn CM, Kameishi S, Parker T, Cho YK, Song SU, Grainger DW, et al. Cellular Interactions in Cell Sheets Enhance Mesenchymal Stromal Cell Immunomodulatory Properties. Tissue Engineering Part A. 2023;29(21-22):594-603. doi:10.1089/ten.tea.2023.0059
BibTeX
@article{Dunn2023,
author = {Dunn, Celia M and Kameishi, Sumako and Parker, Tavie and Cho, Yun-Kyoung and Song, Sun U and Grainger, David W and Okano, Teruo},
title = {Cellular Interactions in Cell Sheets Enhance Mesenchymal Stromal Cell Immunomodulatory Properties},
journal = {Tissue Engineering Part A},
year = {2023},
volume = {29},
number = {21-22},
pages = {594--603},
doi = {10.1089/ten.tea.2023.0059}
}
EUVIMED